144 related articles for article (PubMed ID: 7055802)
41. [Estradiol receptors in the plasma membranes of cells in hormone-dependent mammary tumors].
Morozova TM; Volchkov VE; Merkulova TI; Nagibneva IN
Dokl Akad Nauk SSSR; 1983; 272(6):1494-7. PubMed ID: 6418499
[No Abstract] [Full Text] [Related]
42. Peroxidase activity as a marker for estrogenicity: studies in uterus and mammary tumors.
Levy J; Liel Y; Glick SM
Isr J Med Sci; 1981; 17(9-10):970-5. PubMed ID: 7309486
[TBL] [Abstract][Full Text] [Related]
43. The binding of tamoxifen to oestrogen receptor proteins under equilibrium and non-equilibrium conditions.
Nicholson RI; Syne JS; Daniel CP; Griffiths K
Eur J Cancer (1965); 1979 Mar; 15(3):317-29. PubMed ID: 446514
[No Abstract] [Full Text] [Related]
44. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
45. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
46. The binding of estradiol-17beta to human breast cancers and other tissues in vitro.
Johansson H; Terenius L; Thorén L
Cancer Res; 1970 Mar; 30(3):692-8. PubMed ID: 5463903
[No Abstract] [Full Text] [Related]
47. Oestrogen-binding and the hormone respinsiveness of tumours.
King RJ; Smith JA; Steggles AW
Steroidologia; 1970; 1(2):73-88. PubMed ID: 4938760
[No Abstract] [Full Text] [Related]
48. [Determination of estrogen receptors in tumor tissues--possibilities and limitations].
Hampl R; Kimlová I; Stárka L
Cas Lek Cesk; 1982 Oct; 121(42):1288-93. PubMed ID: 6756636
[No Abstract] [Full Text] [Related]
49. Fluoresceinated estrone binding by cells from human breast cancers obtained by needle aspiration.
Gunduz N; Zheng S; Fisher B
Cancer; 1983 Oct; 52(7):1251-6. PubMed ID: 6883288
[TBL] [Abstract][Full Text] [Related]
50. Estrogen receptor cytochemistry by fluorescent estrogen.
Nenci I; Dandliker WB; Meyers CY; Marchetti E; Marzola A; Fabris G
J Histochem Cytochem; 1980 Oct; 28(10):1081-8. PubMed ID: 7419900
[TBL] [Abstract][Full Text] [Related]
51. Estradiol receptors in mouse mammary tumors: absence of the transfer of bound estradiol from the cytoplasm to the nucleus.
Shyamala G
Biochem Biophys Res Commun; 1972 Feb; 46(4):1623-30. PubMed ID: 5015605
[No Abstract] [Full Text] [Related]
52. Chemotherapeutic agents and estradiol receptor binding capacity.
Görlich M; Heise E; Számel I; Kerpel-Fronius S
Oncology; 1979; 36(4):149-55. PubMed ID: 471426
[TBL] [Abstract][Full Text] [Related]
53. Heterogeneity of estrogen binding sites in mammary tumors.
Clark JH; Watson CS; Markaverich BM; Syne JS; Panko WB
Breast Cancer Res Treat; 1983; 3(1):61-5. PubMed ID: 6871482
[TBL] [Abstract][Full Text] [Related]
54. Equilibrium: the intracellular distribution of steroid receptors.
Sheridan PJ; Buchanan JM; Anselmo VC; Martin PM
Nature; 1979 Dec; 282(5739):579-82. PubMed ID: 551293
[TBL] [Abstract][Full Text] [Related]
55. Cell collection from fine needle aspirates for estrogen receptor immunocytochemical assay.
Earl M
Acta Cytol; 1987; 31(3):377-8. PubMed ID: 3473875
[No Abstract] [Full Text] [Related]
56. [Determination of estrogen receptors in fine-needle aspirates from breast carcinoma. A description of a method].
Lilleng R; Hagmar B; Myrtvedt M; Ottestad L
Tidsskr Nor Laegeforen; 1989 May; 109(15):1630-2. PubMed ID: 2741142
[No Abstract] [Full Text] [Related]
57. Measurement of DNA synthesis by 3H-thymidine incorporation into needle aspirates from human tumors.
Nordenskjöld B; Zetterberg A; Löwhagen T
Acta Cytol; 1974; 18(3):215-21. PubMed ID: 4525221
[No Abstract] [Full Text] [Related]
58. Heterogeneity of estrogen binding sites in mouse mammary cancer.
Watson CS; Clark JH
J Recept Res; 1980; 1(1):91-111. PubMed ID: 7299733
[No Abstract] [Full Text] [Related]
59. Improved gel-filtration method for analysis of estrogen receptor binding.
Godefroi VC; Brooks SC
Anal Biochem; 1973 Feb; 51(2):335-44. PubMed ID: 4349450
[No Abstract] [Full Text] [Related]
60. The status of estrogen receptor of breast cancer cells.
Zheng S; Fisher B; Gunduz N
Chin Med J (Engl); 1985 Aug; 98(8):607-12. PubMed ID: 3937690
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
